Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Stelara (Ustekinumab) Covered by Blue Cross Blue Shield of Michigan: Timeline, Forms, and Appeals Guide

Quick Answer: Getting Stelara Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Stelara (ustekinumab). Key change: Starting April 1, 2025, BCBS Michigan will only cover Yesintek (ustekinumab biosimilar) for most commercial members, not brand-name Stelara. You'll need step therapy (trying preferred alternatives

Get Gilenya (Fingolimod) Covered by Blue Cross Blue Shield of North Carolina: Prior Authorization Forms, Appeals, and Success Strategies

Answer Box: Getting Gilenya Covered in North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Gilenya (fingolimod), typically with step therapy requirements. To get approved: (1) Have your doctor submit a PA request with documentation of failed first-line MS therapies, (2) Include required monitoring plans (EKG,

The Requirements Checklist to Get Advate (octocog alfa) Covered by Blue Cross Blue Shield in Michigan

Answer Box: Getting Advate Covered in Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Advate (octocog alfa) for hemophilia A treatment. The fastest path to approval: (1) Submit complete PA request with Factor VIII inhibitor test results and clinical documentation via provider portal, (2) Include medical necessity

How to Get Mavenclad (Cladribine) Covered by Blue Cross Blue Shield in California: Complete Guide with Appeal Scripts

Answer Box: Getting Mavenclad Covered in California To get Mavenclad (cladribine) covered by Blue Cross Blue Shield in California: (1) Meet prior authorization criteria including relapsing MS diagnosis, failed 2+ preferred DMTs, and normal lymphocyte counts, (2) Submit complete documentation via your neurologist including medical necessity letter and prior therapy

The Requirements Checklist to Get Xospata (gilteritinib) Covered by Blue Cross Blue Shield in Ohio: Forms, Appeals, and Success Tips

Answer Box: Fast-Track Approval for Xospata in Ohio To get Xospata (gilteritinib) covered by Blue Cross Blue Shield in Ohio, you need FLT3 mutation test results, documented relapsed/refractory AML, and a specialist's medical necessity letter. Submit through your plan's provider portal with complete prior authorization

Coding That Helps Get Brensocatib (BRINSUPRI) Approved by Blue Cross Blue Shield in New York: ICD-10, HCPCS, NDC Guide

Answer Box: Getting Brensocatib (BRINSUPRI) Covered in New York Fastest path to approval: Submit prior authorization using ICD-10 code J47.1 (bronchiectasis with exacerbation), NDC from specialty pharmacy, and document failed macrolide therapy. Blue Cross Blue Shield typically covers under pharmacy benefit with specialty tier requirements. If denied, file internal

How to Get Gilenya (Fingolimod) Covered by Blue Cross Blue Shield in Georgia: Appeals Guide & Templates

Quick Answer: Getting Gilenya Covered by Blue Cross Blue Shield in Georgia Your fastest path to approval: 1) Submit prior authorization with baseline EKG, ophthalmic exam, and documented failure of preferred MS therapies. 2) If denied, file internal appeal within 180 days with medical necessity letter. 3) Request external review

Qalsody (Tofersen) Approval with Blue Cross Blue Shield in Ohio: Complete Guide to Coverage, Appeals, and State Protections

Answer Box: Getting Qalsody Covered by Blue Cross Blue Shield in Ohio Qalsody (tofersen) is typically covered by Blue Cross Blue Shield Ohio plans for adults with SOD1-mutation ALS, but requires prior authorization and specialty pharmacy dispensing. The fastest path to approval: 1) Confirm SOD1 genetic testing results, 2) Have

How to Get Tysabri (Natalizumab) Covered by Blue Cross Blue Shield of North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Tysabri Covered by BCBS North Carolina Eligibility: Tysabri (natalizumab) requires prior authorization from Blue Cross Blue Shield of North Carolina for both commercial and Medicare members. Coverage is typically approved for relapsing multiple sclerosis when step therapy requirements are met and proper clinical documentation is provided. Fastest

Blue Cross Blue Shield North Carolina Coverage Criteria for Tecentriq (Atezolizumab): Complete Prior Authorization Guide

Answer Box: Getting Tecentriq Covered by BCBS North Carolina Tecentriq (atezolizumab) requires prior authorization from Blue Cross Blue Shield of North Carolina for all plan types. To get approved: (1) Submit PA request with FDA-approved indication, clinical notes, and required biomarker testing (PD-L1 for NSCLC), (2) Document any prior therapy